Penicillium  ||| S:0 E:12 ||| JJ
chrysogenum  ||| S:12 E:24 ||| NNS
DSOA  ||| S:24 E:29 ||| VBP
associated  ||| S:29 E:40 ||| VBN
with  ||| S:40 E:45 ||| IN
marine  ||| S:45 E:52 ||| JJ
sponge  ||| S:52 E:59 ||| NNS
( ||| S:59 E:60 ||| -LRB-
Tedania  ||| S:60 E:68 ||| UH
anhelans ||| S:68 E:76 ||| UH
)  ||| S:76 E:78 ||| -RRB-
exhibit  ||| S:78 E:86 ||| NN
antimycobacterial  ||| S:86 E:104 ||| NN
activity  ||| S:104 E:113 ||| NN
A  ||| S:113 E:115 ||| DT
strain  ||| S:115 E:122 ||| NN
of  ||| S:122 E:125 ||| IN
Penicillium  ||| S:125 E:137 ||| NNP
chrysogenum  ||| S:137 E:149 ||| NN
was  ||| S:149 E:153 ||| VBD
isolated  ||| S:153 E:162 ||| VBN
from  ||| S:162 E:167 ||| IN
Tedania  ||| S:167 E:175 ||| NNP
anhelans  ||| S:175 E:184 ||| NNS
( ||| S:184 E:185 ||| -LRB-
marine  ||| S:185 E:192 ||| FW
sponge ||| S:192 E:198 ||| FW
)  ||| S:198 E:200 ||| -RRB-
collected  ||| S:200 E:210 ||| VBN
from  ||| S:210 E:215 ||| IN
Indian  ||| S:215 E:222 ||| NNP
Ocean  ||| S:222 E:228 ||| NNP
( ||| S:228 E:229 ||| -LRB-
8°22 ||| S:229 E:233 ||| NNP
' ||| S:233 E:234 ||| POS
30″N  ||| S:234 E:239 ||| JJ
latitude  ||| S:239 E:248 ||| NN
and  ||| S:248 E:252 ||| CC
76°59 ||| S:252 E:257 ||| NNP
' ||| S:257 E:258 ||| POS
16″  ||| S:258 E:262 ||| CD
longitude ||| S:262 E:271 ||| CD
)  ||| S:271 E:273 ||| -RRB-
and  ||| S:273 E:277 ||| CC
deposited  ||| S:277 E:287 ||| NN
in  ||| S:287 E:290 ||| IN
culture  ||| S:290 E:298 ||| NN
collection  ||| S:298 E:309 ||| NN
centers ||| S:309 E:316 ||| NNS
.  ||| S:316 E:318 ||| .
The  ||| S:318 E:322 ||| DT
strain  ||| S:322 E:329 ||| NN
subjected  ||| S:329 E:339 ||| VBN
to  ||| S:339 E:342 ||| TO
different  ||| S:342 E:352 ||| JJ
culture  ||| S:352 E:360 ||| NN
conditions  ||| S:360 E:371 ||| NNS
for  ||| S:371 E:375 ||| IN
production  ||| S:375 E:386 ||| NN
of  ||| S:386 E:389 ||| IN
extrolites  ||| S:389 E:400 ||| NN
were  ||| S:400 E:405 ||| VBD
extracted  ||| S:405 E:415 ||| VBN
using  ||| S:415 E:421 ||| VBG
ethyl  ||| S:421 E:427 ||| JJ
acetate  ||| S:427 E:435 ||| NN
and  ||| S:435 E:439 ||| CC
chloroform ||| S:439 E:449 ||| NN
.  ||| S:449 E:451 ||| .
When  ||| S:451 E:456 ||| WRB
both  ||| S:456 E:461 ||| DT
extracts  ||| S:461 E:470 ||| NN
were  ||| S:470 E:475 ||| VBD
subjected  ||| S:475 E:485 ||| VBN
for  ||| S:485 E:489 ||| IN
antibacterial  ||| S:489 E:503 ||| JJ
activity ||| S:503 E:511 ||| NN
,  ||| S:511 E:513 ||| ,
latter  ||| S:513 E:520 ||| NN
had  ||| S:520 E:524 ||| VBD
high  ||| S:524 E:529 ||| JJ
activity ||| S:529 E:537 ||| NN
.  ||| S:537 E:539 ||| .
Minimum  ||| S:539 E:547 ||| JJ
inhibitory  ||| S:547 E:558 ||| JJ
concentration  ||| S:558 E:572 ||| NN
of  ||| S:572 E:575 ||| IN
chloroform  ||| S:575 E:586 ||| JJ
extract  ||| S:586 E:594 ||| NN
ranged  ||| S:594 E:601 ||| VBD
from  ||| S:601 E:606 ||| IN
31.25-1000μg ||| S:606 E:618 ||| CD
/ ||| S:618 E:619 ||| CD
mL  ||| S:619 E:622 ||| NN
in  ||| S:622 E:625 ||| IN
tested  ||| S:625 E:632 ||| JJ
microbes  ||| S:632 E:641 ||| NNS
such  ||| S:641 E:646 ||| JJ
as ||| S:646 E:648 ||| RB
,  ||| S:648 E:650 ||| ,
Mycobacterium  ||| S:650 E:664 ||| NNP
tuberculosis  ||| S:664 E:677 ||| VBD
H37Ra ||| S:677 E:682 ||| CD
,  ||| S:682 E:684 ||| ,
Mycobacterium  ||| S:684 E:698 ||| NNP
avium ||| S:698 E:703 ||| NN
,  ||| S:703 E:705 ||| ,
Mycobacterium  ||| S:705 E:719 ||| NNP
fortuitum ||| S:719 E:728 ||| NN
,  ||| S:728 E:730 ||| ,
Mycobacterium  ||| S:730 E:744 ||| NNP
smegmatis ||| S:744 E:753 ||| NN
,  ||| S:753 E:755 ||| ,
Mycobacterium  ||| S:755 E:769 ||| NNP
vaccae ||| S:769 E:775 ||| NN
,  ||| S:775 E:777 ||| ,
Staphylococcus  ||| S:777 E:792 ||| NNP
aureus ||| S:792 E:798 ||| NN
,  ||| S:798 E:800 ||| ,
Aeromonas  ||| S:800 E:810 ||| NNP
hydrophila ||| S:810 E:820 ||| NN
,  ||| S:820 E:822 ||| ,
Pseudomonas  ||| S:822 E:834 ||| NNP
aeruginosa  ||| S:834 E:845 ||| NN
and  ||| S:845 E:849 ||| CC
Vibrio  ||| S:849 E:856 ||| NNP
cholerae ||| S:856 E:864 ||| NN
.  ||| S:864 E:866 ||| .
No  ||| S:866 E:869 ||| DT
cytotoxicity  ||| S:869 E:882 ||| NN
was  ||| S:882 E:886 ||| VBD
observed  ||| S:886 E:895 ||| VBN
in  ||| S:895 E:898 ||| IN
Vero  ||| S:898 E:903 ||| NNP
cell  ||| S:903 E:908 ||| NN
line  ||| S:908 E:913 ||| NN
up  ||| S:913 E:916 ||| RP
to  ||| S:916 E:919 ||| TO
399.10μg ||| S:919 E:927 ||| CD
/ ||| S:927 E:928 ||| CD
mL ||| S:928 E:930 ||| NN
.  ||| S:930 E:932 ||| .
Antibacterial  ||| S:932 E:946 ||| JJ
activity  ||| S:946 E:955 ||| NN
previously  ||| S:955 E:966 ||| RB
reported  ||| S:966 E:975 ||| VBN
by  ||| S:975 E:978 ||| IN
Parameswaran  ||| S:978 E:991 ||| NNP
et  ||| S:991 E:994 ||| NNP
al.  ||| S:994 E:998 ||| NNP
in  ||| S:998 E:1001 ||| IN
1997  ||| S:1001 E:1006 ||| CD
from  ||| S:1006 E:1011 ||| IN
ethyl  ||| S:1011 E:1017 ||| JJ
acetate  ||| S:1017 E:1025 ||| JJ
extract  ||| S:1025 E:1033 ||| NN
of  ||| S:1033 E:1036 ||| IN
T.  ||| S:1036 E:1039 ||| NNP
anhelans  ||| S:1039 E:1048 ||| NN
might  ||| S:1048 E:1054 ||| MD
be  ||| S:1054 E:1057 ||| VB
due  ||| S:1057 E:1061 ||| JJ
to  ||| S:1061 E:1064 ||| TO
the  ||| S:1064 E:1068 ||| DT
diketopiperazines ||| S:1068 E:1085 ||| NN
,  ||| S:1085 E:1087 ||| ,
Cyclo- ||| S:1087 E:1093 ||| NNP
( ||| S:1093 E:1094 ||| -LRB-
l-Pro-l-Phe ||| S:1094 E:1105 ||| NNP
)  ||| S:1105 E:1107 ||| -RRB-
and  ||| S:1107 E:1111 ||| CC
Cyclo- ||| S:1111 E:1117 ||| NNP
( ||| S:1117 E:1118 ||| -LRB-
l-Leu-l-Pro ||| S:1118 E:1129 ||| NNP
)  ||| S:1129 E:1131 ||| -RRB-
produced  ||| S:1131 E:1140 ||| VBN
by  ||| S:1140 E:1143 ||| IN
the  ||| S:1143 E:1147 ||| DT
associated  ||| S:1147 E:1158 ||| FW
fungi-P.  ||| S:1158 E:1167 ||| FW
chrysogenum  ||| S:1167 E:1179 ||| FW
DSOA ||| S:1179 E:1183 ||| FW
.  ||| S:1183 E:1185 ||| .
It  ||| S:1185 E:1188 ||| PRP
is  ||| S:1188 E:1191 ||| VBZ
producing  ||| S:1191 E:1201 ||| VBG
a  ||| S:1201 E:1203 ||| DT
metabolites  ||| S:1203 E:1215 ||| NN
having  ||| S:1215 E:1222 ||| VBG
antimycobacterial  ||| S:1222 E:1240 ||| JJ
activity ||| S:1240 E:1248 ||| NN
,  ||| S:1248 E:1250 ||| ,
a  ||| S:1250 E:1252 ||| DT
first  ||| S:1252 E:1258 ||| JJ
report ||| S:1258 E:1264 ||| NN
.  ||| S:1264 E:1266 ||| .
